# LBB Specialties Holdings LLC – FDA Inspection, Jun 26, 2019

Source: https://www.keypedia.com/records/fda_inspections/lbb-specialties-holdings-llc/06616e2f-fc39-4ed2-9b8d-143b400e6791
Source feed: FDA_Inspections

> FDA inspection 1094198 of LBB Specialties Holdings LLC, June 26, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1094198
- Company Name: LBB Specialties Holdings LLC
- Inspection Date: 2019-06-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1282312 - 2025-09-15
- [FDA Inspection 1250187 - 2024-09-27](https://www.keypedia.com/records/fda_inspections/lbb-specialties-holdings-llc/a079615d-9669-4f45-88d7-cf4616a22145)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/erik-w-koester/2bbab081-6783-40a1-83c1-b219bde22bd1)
- [Robert J. Martin](https://www.keypedia.com/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae)

Company: https://www.keypedia.com/companies/lbb-specialties-holdings-llc/2960d723-d60c-4a5c-a632-fc05fd323ebe

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c